Modulation of the immune system by Boswellia serrata extracts and boswellic acids

Phytomedicine

Volumn 17, Issue 11, 2010, Pages 862-867

  Ammon, H P T ^a  

^a UNIVERSITY OF TÜBINGEN   (Germany)

Author keywords

Boswellia serrata extracts; Boswellic acids; Immune system

Indexed keywords

11 KETO BETA BOSWELLIC ACID; ACETYL 11 OXO BETA BOSWELLIC ACID; ANTIINFLAMMATORY AGENT; BOSWELLIA SERRATA EXTRACT; BOSWELLIC ACID; COMPLEMENT COMPONENT C3; COMPLEMENT COMPONENT C3A; COMPLEMENT COMPONENT C3B; GAMMA INTERFERON; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 1; INTERLEUKIN 2; INTERLEUKIN 4; INTERLEUKIN 6; LEUKOTRIENE; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ANTIBODY TITER; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CELLULAR IMMUNITY; COMPLEMENT SYSTEM; CYTOKINE PRODUCTION; DOWN REGULATION; HUMORAL IMMUNITY; IMMUNOMODULATION; INFLAMMATION; LYMPHOCYTE PROLIFERATION; MACROPHAGE; MAST CELL; MOUSE; NEUTROPHIL GRANULE; NONHUMAN; PHAGOCYTOSIS; PRIORITY JOURNAL; PROSTAGLANDIN SYNTHESIS INHIBITION;

ANIMALS; ANTIOXIDANTS; BOSWELLIA; IMMUNE SYSTEM; IMMUNOLOGIC FACTORS; PLANT EXTRACTS; RESINS, PLANT; TRITERPENES;

ACIS; BOSWELLIA SERRATA; OVIS ARIES;

EID: 77955983183     PISSN: 09447113     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.phymed.2010.03.003     Document Type: Article

References (31)

1. Ammon H.P., Mack T., Singh G.B., Safayhi H. Inhibition of leukotriene B4 formation in rat peritoneal neutrophils by an ethanolic extract of the gum resin exudates of Boswellia serrata. Planta Med. 1991, 57:203-207.
2. Ammon H.P., Safayhi H., Mack T., Sabieraj J. Mechanism of antiinflammatory actions of curcumine and boswellic acids. J. Ethnopharmacol. 1993, 38:113-119.
3. Badria F.A., Mikhaeil B.R., Maatooq G.T., Amer M.M. Immunmodulatory terpenoids from the oleogum resin of Boswellia carterii Birdwood. Z. Naturforsch. 2003, 58:506-516.
4. Chervier M.R., Ryan A.E., Lee D.Y., Zhongze M., Wu-Yan Z., Via C.S. Boswellia carterii extract inhibits TH1 cytokines and promotes TH2 cytokines in vitro. Clin. Diagn. Lab. Immunol. 2005, 1:575-580.
5. Cuaz-Pérolin C., Billiet L., Baugé E., Copin C., Scott-Algara D., Genze F., Büchele B., Syrovets T., Simmet T., Rouis M. Antiinflammatory and antiatherogenic effects of NF-Kappa B inhibitor acetyl-11-beta-boswellic acid in LPS-challenged ApoE -/- mice. Arterioscler. Thromb. Vasc. Biol. 2008, 28:272-277.
6. Etzel R. special extract of Boswellia serrata (H15) in the treatment of reumatoid arthritis. Phytomedicine 1996, 3:91-94.
7. Gayathri B., Manjula N., Vinaykumar K.S., Lakshmi B.S., Balakrishnan A. Pure compound from Boswellia serrata extract exhibits anti-inflammatory property in human PBMCs and mouse macrophages through inhibition of TNF alpha, IL-1beta, NO and MAP kinases. Int. Immunopharmacol. 2007, 7:473-482.
8. Gerhardt H., Seifert F., Buvari P., Vogelsang H., Repges R.Z. Therapie des aktiven Morbus Crohn mit Boswellia serrata extract H 15. Z. Gastroenterol. 2001, 39:11-17.
9. Gupta O.P., Sharma N., Chand D. A sensitive and relevant model for evaluating anti-inflammatory activity-papaya latex-induced rat paw inflammatione. J. Pharmacol. Toxicol. 1992, 28:15-19.
10. Gupta I., Parihar A., Malhotra P., Singh G.B., Ludtke R., Safayhi H., et al. Effects of Boswellia serrata gum resin in patients with ulcerative colitis. Eur. J. Med. Res. 1997, 2:37-43.
11. Gupta I., Gupta V., Parihar A., Gupta S., Ludtke R., Safayhi H., et al. Effects of Boswellia serrata gum resin in patients with bronchial asthma: results of a double-blind, placebo-controlled, 6 week clinical study. Eur. J. Med. Res. 1998, 3:511-514.
12. Heil K., Ammon H.P., Safayhi H. Inhibition of NADPH-oxidase by AKBA in intact PMNs. Naunyn Schmiedebergs Arch. Pharmacol. 2001, 363S:R14.
13. Kapil A., Moza N. Anticomplementary activity of Boswellia acids-an inhibitor of C3-convertase of the classical complement pathway. Int. J. Immunopharmacol. 1991, 14:1139-1143.
14. Khajuria A., Gupta A., Suden P., Singh S., Malik F., Singh J., Gupta B.D., Suri K.A., Srinavas V.K., Ella K., Quazi G.N. Immunmodulatory activity of biopolymeric fraction BOS 2000 from Boswellia serrata. Phytother. Res. 2008, 22:340-348.
15. Kimmatkar N., Thawani V., Hingorani L., Khiyani R. Efficacy and tolerability of Boswellia serrata extract in treatment of osteoarthritis of knee-a randomized double blind placebo controlled trial. Phytomedicine 2003, 10:3-7.
16. Moussaieff A., Shohami E., Kashman Y., Fride E., Schmitz M.L., Renner F., Fiebich B.L., Munoz E., Ben-Neriah Y., Mechoulam R. Incensolate acetate, a novel anti-inflammatory compound isolated from Boswellia resin, inhibits nuclear factor-kappa B activation. Mol. Pharmacol. 2007, 72:1657-1664.
17. Pungle P., Banavalikar M., Suthar A., Biyani M., Mengi S. Immunomo-dulatory activity of boswellic acids of Boswellia serrata Roxb. Indian J. Exp. Biol. 2003, 41:1460-1462.
18. Roy S., Khanna S., Shah H., Rink C., Phillips C., Preuss H., et al. Human genome screen to identify the genetic basis of the anti-inflammatory effects of Boswellia in microvascular endothelial cells. DNA Cell Biol. 2005, 24:244-255.
19. Safayhi H., Mack Th., Sabieraj J., Anazodo M.I., Subramanian L.R., Ammon H.P. Boswellic acids: novel, specific nonredox inhibitors of 5-lipoxygenase. J. Pharmacol. Exp. Ther. 1992, 261:1143-1146.
20. Safayhi H., Rall B., Sailer E.R., Ammon H.P. Inhibition by boswellic acids of human leukocyte elastase. J. Pharmacol. Exp. Ther. 1997, 281:460-463.
21. Sailer E.R., Subramanian L.R., Rall B., Hoernlein R.F., Ammon H.P., Safayhi H. Acetyl-11-keto-beta-boswellic acid (AKBA): structure requirements for binding and 5-lipoxygenase inhibitory activity. Br. J. Pharmacol. 1996, 117:615-618.
22. Sauer A., Aigner J., Hartung T., Minuth W., Wendel A. Granulocyte mediated hepatotoxicity after endotoxin stimulation depends on adhesion and elastase release. Naunyn Schmiedebergs Arch. Pharmacol. 1995, 351S. A 495.
23. ® for treatment of osteoarthritis of the knee. Arthritis Res. Ther. 2008, 10(4):R 85.
24. Sharma M.L., Kaul A., Khajuria A., Singh S., Singh G.B. Immunomodulatory activity of boswellic acids (pentacyclic triterpene acids) from Boswellia serrata. Phytother. Res. 1996, 10:107-112.
25. Siemoneit U., Hofmann B., Kather N., Lamkemeyer T., Madlung J., Franke L., Schneider G., Jauch J., Poeckel D., Werz O. Identification and functional analysis of cyclooxygenase-1 as a molecular target of boswellic acids. Biochem. Pharmacol. 2008, 75:503-513.
26. Siemoneit U., Pergola C., Jazzar B., Northoff H., Skarke C., Jauch J., Werz O. On the interference of boswellic acids with 5-lipoxygenase: Mechanistic studies in vitro and pharmacological relevance. Eur. J. Pharmacol. 2009, 606:246-254.
27. Singh G.B., Atal C.K. Pharmacology of an extract of salai guggal ex Boswellia serrata, a new non-steroidal anti-inflammatory agent. Agents Actions 1986, 18:407-412.
28. Sontakke S., Thawani V., Pimpalkhute S., et al. Open, randomized, controlled clinical trial of Boswellia serrata extract as compared to valdecocib in osteoarthritis of knee. Indian J. Pharmacol. 2007, 39:27-29.
29. Sterk V., Büchele B., Simmet T. Effect of food intake on the bioavailability of boswellic acids from a herbal preparation in healthy volunteers. Planta. Med. 2004, 70:1155-1160.
30. Syrovets T., Buchele B., Krauss C., Laumonnier Y., Simmet T. Acetyl-boswellic acids inhibit lipopolysaccharide-mediated TNF-alpha induction in monocytes by direct interaction with IkappaB kinase. J. Immunol. 2005, 174:498-506.
31. Wagner H., Knaus W., Jordan E. Pflanzeninhaltsstoffe mit Wirkung auf das Komplementsystem. Z. Phytother. 1987, 8:148-149.